Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

for the LEADER Steering Committee on behalf of the LEADER Trial Investigators, Alan Jaap (Member of Group Organisation)

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)311-322
JournalNew England Journal of Medicine
Volume375
Issue number4
DOIs
Publication statusPublished - 28 Jul 2016

Cite this